Hypophosphatasia (HPP) is a rare genetic condition that softens your bones and can cause you to lose your teeth earlier than usual. It has seven major forms that range in severity and age of onset. The symptoms of HPP vary based on the form.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Hypophosphatasia (HPP) is a rare genetic (inherited) condition that affects how your bones and teeth develop. Specifically, it makes them soft and weak by affecting how they mineralize (calcify). HPP is a type of metabolic bone disease.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
HPP ranges widely in severity. At its most mild, it significantly increases your risk of stress fractures in middle age. At its most severe, it can result in stillbirth or death shortly after birth.
There are seven major forms of hypophosphatasia based on the age at which symptoms begin and their severity. The types of HPP from most to least severe include:
Hypophosphatasia is rare in the general population. Severe forms affect 1 in 100,000 to 1 in 300,000 babies born each year. But mild forms of the condition (like adult HPP) are more common. They affect around 1 in 6,000 to 1 in 7,000 people.
Of note, HPP is more frequent in the Mennonite population in Manitoba, Canada. About 1 in 2,500 babies in this population have severe forms of the condition.
Advertisement
Hypophosphatasia causes lots of different symptoms. No two cases are the same — even cases within the same biological family. Which symptoms you experience usually depends on which type of HPP you have.
Healthcare providers can usually see signs of perinatal HPP in fetuses via ultrasound during pregnancy. They include:
Some pregnancies end in stillbirth. Some babies born with perinatal HPP may die after several days from respiratory failure due to chest weakness.
At birth, infants with perinatal benign HPP have bowed arms and legs. Healthcare providers can typically see this with ultrasound during the pregnancy.
The bone malformations improve gradually after birth. The symptoms that later develop can range from those of infantile HPP to odontohypophosphatasia.
Symptoms of infantile HPP usually become noticeable within the first six months of a baby’s life. They may include:
In some cases, the bone mineralization issues in infantile HPP can improve randomly during early childhood. But it’s still important to get treatment to avoid permanent complications like a short stature and misshapen bones.
Childhood HPP can range from mild to severe. Symptoms can include:
In some cases, childhood HPP can spontaneously improve in young adulthood. But complications can return during middle age or late adulthood.
Adult HPP has wide-ranging symptoms, which may include:
Advertisement
Odontohypophosphatasia only affects your teeth — not your skeletal bones. The main signs are losing your baby teeth prematurely — in infancy or early childhood. Some people experience unexpected adult tooth loss in adulthood.
Genetic variants (changes) cause hypophosphatasia — specifically, variants in the ALPL gene. Normally, this gene provides instructions for your body to make an enzyme called tissue-nonspecific alkaline phosphatase (TNSALP). This enzyme is necessary for your bones and teeth to mineralize (harden). Variants that affect how the ALPL gene produces TNSALP mean that it can’t do its job properly (or at all).
Bone mineralization is the process by which the bone matrix becomes filled with calcium phosphate nanocrystals (the “hard” substances in your bones). Bone matrix is made of proteins like collagen mixed with calcium, phosphate and other minerals.
Genetic variants that almost completely block the function of TNSALP usually result in the more severe forms of hypophosphatasia. Other variants, which reduce but don’t totally block the activity of TNSALP, often cause milder forms of the condition.
You inherit the severe forms of hypophosphatasia, like perinatal hypophosphatasia, in an autosomal recessive pattern. This means that both biological parents need to pass an altered ALPL gene on to their child. In most cases, biological parents don’t experience HPP symptoms and don’t know they carry the gene variant that causes it.
Advertisement
Milder forms of hypophosphatasia can have either an autosomal recessive or an autosomal dominant pattern. The latter pattern means that only one biological parent needs to have an altered ALPL gene to pass it on to their child.
Healthcare providers use physical exams, imaging tests and laboratory tests to diagnose hypophosphatasia. Providers who are familiar with the condition typically spot it quickly. But it may take longer for providers who are unfamiliar with HPP to diagnose it.
Tests that can help lead to an HPP diagnosis include:
Advertisement
There’s no cure for hypophosphatasia. But a medication injection called asfotase alfa (Strensiq®) is the main treatment that can help manage it. It’s a subcutaneous (under the skin) injection that works as a TNSALP enzyme replacement therapy. Children and adults who develop symptoms in childhood can use the medication.
Studies show that asfotase alfa can improve breathing function, calcium levels, bone health and survival in children with the infantile and early childhood (juvenile) type of HPP.
Other treatments for HPP mainly help to manage specific symptoms and complications. Your child may need a team of experts for their care, including:
Examples of supportive treatments include:
You can’t prevent hypophosphatasia because it’s a genetic condition.
Talk to your healthcare provider about genetic counselingif you’re concerned about the risk of passing on hypophosphatasia or other genetic conditions to your biological children.
It’s important to remember that no two people with hypophosphatasia are affected in the same way. It’s impossible to predict how the condition will affect your child as they grow. The best way you can prepare is to talk to healthcare providers who specialize in researching and treating HPP, if possible. They’ll tell you which symptoms or changes to look out for and what the future might hold.
If your child has HPP, it’s important to advocate for them to ensure they get the best medical care. Some healthcare providers you come across may not be familiar with this rare condition. Advocating for care can help your child have the best possible quality of life.
You and your family may also want to consider joining a support group to meet others who can relate to your experiences.
If your child has hypophosphatasia, they’ll need to see their team of healthcare providers regularly to receive treatment and monitor their symptoms.
Understanding your child’s hypophosphatasia diagnosis can be overwhelming. Know that your child’s healthcare team will offer a robust management and monitoring plan that’s unique to them. It’s important to make sure you, your child and your family are getting the support you need and to stay attentive to your child’s health. Your child’s healthcare team will be there to support them and your family every step of the way.
Last reviewed on 12/03/2024.
Learn more about the Health Library and our editorial process.